Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,781
  • Shares Outstanding, K 29,589
  • Annual Sales, $ 2,900 K
  • Annual Income, $ -6,800 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 0.89
  • Price/Sales 19.44
  • Price/Cash Flow N/A
  • Price/Book 16.46

Options Overview Details

View History
  • Implied Volatility 376.47% ( +155.37%)
  • Historical Volatility 141.72%
  • IV Percentile 95%
  • IV Rank 63.92%
  • IV High 563.82% on 11/11/24
  • IV Low 44.57% on 06/13/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 190
  • Volume Avg (30-Day) 746
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 10,950
  • Open Int (30-Day) 8,613

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.01
  • Low Estimate -0.07
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 +40.00%
on 11/21/24
2.2000 -20.45%
on 12/18/24
+0.2600 (+17.45%)
since 11/20/24
3-Month
0.9257 +89.05%
on 10/01/24
2.2000 -20.45%
on 12/18/24
+0.5000 (+40.00%)
since 09/20/24
52-Week
0.9257 +89.05%
on 10/01/24
2.6700 -34.46%
on 06/06/24
+0.1900 (+12.18%)
since 12/20/23

Most Recent Stories

More News
Dyadic International Receives $3 Million Grant from Gates Foundation for Monoclonal Antibody Development Targeting RSV and Malaria

Dyadic International received a $3 million Gates Foundation grant for developing monoclonal antibodies targeting RSV and malaria.Quiver AI SummaryDyadic International, Inc., a biotechnology company, has...

DYAI : 1.7500 (-8.14%)
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

DYAI : 1.7500 (-8.14%)
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

DYAI : 1.7500 (-8.14%)
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

DYAI : 1.7500 (-8.14%)
Dyadic Expands Global Presence with Participation in Key Industry Events

DYAI : 1.7500 (-8.14%)
Dyadic International, Inc Invites You to Join Us at The Microcap Conference

Jupiter, Florida--(Newsfile Corp. - January 22, 2024) - Dyadic International, Inc (NASDAQ: DYAI), Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial platforms...

DYAI : 1.7500 (-8.14%)
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments

Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support...

DYAI : 1.7500 (-8.14%)
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022

JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global...

DYAI : 1.7500 (-8.14%)
Dyadic to Participate in Bio-Manufacturing Innovation Summit and NIIMBL National Meeting

JUPITER, Fla., July 05, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...

DYAI : 1.7500 (-8.14%)
Dyadic to Participate in Three Upcoming Industry Events

JUPITER, Fla., June 09, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...

DYAI : 1.7500 (-8.14%)

Business Summary

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms...

See More

Key Turning Points

3rd Resistance Point 2.2903
2nd Resistance Point 2.1703
1st Resistance Point 1.9601
Last Price 1.7500
1st Support Level 1.6299
2nd Support Level 1.5099
3rd Support Level 1.2997

See More

52-Week High 2.6700
Fibonacci 61.8% 2.0037
Fibonacci 50% 1.7979
Last Price 1.7500
Fibonacci 38.2% 1.5920
52-Week Low 0.9257

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar